Cite
HARVARD Citation
Otten, A. et al. (n.d.). P606 Use of TNF-α-antagonists and systemic steroids is associated with attenuated immunogenicity against SARS-CoV-2 in fully vaccinated patients with Inflammatory Bowel Disease. Journal of Crohn's and colitis. p. i538. [Online].